Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Loan Extension

26 Nov 2014 07:00

RNS Number : 9969X
Fitbug Holdings PLC
26 November 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

26 November 2014

Fitbug Holdings plc ('Fitbug' or 'the Company')

Agreed extension of loans to mid-2016 strengthens balance sheet

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, is pleased to announce that it has agreed that the repayment date of all loans, totalling £6.94 million, to the Company from NW1 Investments Limited will be extended to 31 July 2016. Other terms remain unchanged including the interest rate which remains at 5%.

 

NW1 Investments Limited is a company in which the family of David Turner and Allan Fisher, both directors of Fitbug, have a material interest.

 

Fergus Kee, Chairman of Fitbug said, "We are pleased to have reached an agreement to extend the repayment date on our existing loans with NW1 Investments. It strengthens our balance sheet at an exciting time for Fitbug as we move to scale up the business to meet growing demand for wearable technology."

 

**ENDS**

For further information visit www.KiQplan.com or www.fitbugholdings.com contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce

Hybridan LLP

0203 713 4580

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

Notes

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement. Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. Increasingly, Fitbug's platforms act as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com and www.KiQplan.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRFEWEFIFLSEFF
Date   Source Headline
19th Feb 20187:00 amRNSUpdate
27th Nov 20171:29 pmRNSTR-1: notification of major holdings
23rd Nov 20177:50 amRNSHolding(s) in Company
21st Nov 20178:13 amRNSHolding(s) in Company
17th Nov 20174:39 pmRNSTR-1: notification of major holdings
17th Nov 20174:38 pmRNSTR-1: notification of major holdings
15th Nov 201710:33 amRNSDirector/PDMR Shareholding - Issue of Warrants
15th Nov 20178:05 amRNSChange of Registered Office, Co. Secretary & TVR
15th Nov 20178:01 amRNSBoard changes effective
15th Nov 20177:00 amRNSUpdate on Suspension, CVA, Placing
14th Nov 20177:00 amRNSDirector/PDMR Shareholding
13th Nov 201711:06 amRNSResult of General Meeting
27th Oct 20177:00 amRNSConsolidation of share capital & GM Notice
26th Oct 20177:00 amRNSSuspension update & proposed share consolidation
25th Oct 20174:42 pmRNSTotal Number of CVA Capitalisation Shares
24th Oct 20171:08 pmRNSResult of CVA and General Meeting
5th Oct 20177:00 amRNSProposed CVA, Placing and Board Changes update
3rd Oct 20175:01 pmRNSProposed CVA, Placing and proposed Board Changes
28th Sep 20177:00 amRNSInterim results for six months ended 30 June 2017
11th Sep 20175:39 pmRNSUpdate re suspension
31st Aug 20179:40 amRNSUpdate re suspension: Administrators appointed
23rd Aug 20172:56 pmRNSUpdate re suspension
20th Jul 20179:19 amRNSLoan Note Conversion, Issue of Warrants & Equity
18th Jul 20177:30 amRNSStatement re. Suspension
18th Jul 20177:30 amRNSSuspension - Kin Group plc
7th Jul 20173:15 pmRNSTR-1: Notification of major interest in shares
3rd Jul 20177:00 amRNSConversion of loan notes, issue of warrants &TVR
20th Jun 20177:00 amRNSNon Regulatory - new contract - NHS Trust
14th Jun 20177:00 amRNSGrant of Options
13th Jun 20177:00 amRNSConvertible Loan Notes update
30th May 20177:00 amRNSConversion of Loan Notes, Issue of Warrants & TVR
15th May 20177:00 amRNSConvertible Loan Note Facility
5th May 201712:16 pmRNSResult of AGM, Change of Name and TVRs
11th Apr 20173:06 pmRNSPosting of Annual Report and Notice of AGM
11th Apr 20177:00 amRNSNon Regulatory - Customer renewal
5th Apr 20171:27 pmRNSPublication of Annual Report & Accounts
4th Apr 20177:00 amRNSProposed Change of Name
3rd Apr 20177:00 amRNSFinal Results for the year ended 31 December 2016
22nd Feb 20177:00 amRNSNon Regulatory - New client contract win
16th Feb 20177:00 amRNSNon Regulatory - Results of Case Study
13th Feb 20177:00 amRNSChange of Registered Office
25th Jan 20177:00 amRNSCompletion of Placing
19th Jan 20171:30 pmRNSRestoration - Fitbug Holdings plc
19th Jan 201712:57 pmRNSTrading Update
18th Jan 20173:23 pmRNSSuspension - Fitbug Holdings Plc
18th Jan 20177:00 amRNSNew customer win covering 14,000 employees
16th Jan 20177:00 amRNSChange of Adviser
13th Dec 20167:00 amRNSCorporate Wellness Partnership
8th Nov 20167:00 amRNSDirectorate Change
21st Sep 201611:15 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.